Clinical - paraclinical aspects of viral sars-cov 2 pneumonia in patients with type ii diabetes
Keywords:
COVID-19, Viral pneumonia, type II diabetesAbstract
Pneumonia SARS Cov2 in patients with type 2 diabetes has a difficult evolution with serious complications. The purpose of the learning was to study the clinical and paraclinical aspects of SARS CoV2 pneumonia in patients with type II diabetes. A retrospective study was carried out, which included 47 observation sheets of patients with SARS CoV2 viral pneumonia treated in the pneumology department of MCH “Sf. Arhangel Mihail”. Patients were divided into two groups: in group 1-34 patients with SARS CoV2 pneumonia and type II diabetes and group 2 - 13 patients with SARS CoV2 viral pneumonia without diabetes. According to the obtained results, dyspnea was found in all patients included in the study, and cough was present in a higher number of patients in group I (85,29% vs 76,9%). Conclusions: Pneumonia SARS CoV2 in patients with type II diabetes has a more difficult evolution (long-term fever, later and less obvious resorption of pulmonary infiltrate, longer duration of hospitalization) than in patients without diabetes.
References
1. Pneumonia SARS CoV2 la pacienții cu DZ II are o evoluție mai severă (febra de durată, resorbția infiltratului pulmonar mai tardivă și mai puțin evidentă, durata spitalizării mai lungă) decât la pacienții fără diabet.
2. Infecția SARSCoV2 poate decompensa DZ II și poate predispune pacienții fără diabet în antecedente către această patologie. Churruca M., Martinez-Besteiro El., Counago F. and Landete P. COVID-19 pneumonia: A review of typical radiological characteristics. Radiol. 2021 Oct.28: 13(10):327-343. Published online2021Oct28. doi:10.4329/wjr.v.13i10.327 PMCID: 34786188. 2. Cromer S. J., Colling C., Schatoff D., Leary M., Stamou M. I., Selen D. J., Putman M. S., Wexler D. J. Deborah J.W. Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes //Journal of Diabetes and its Complications, Vol. 36, Is 4, April 2022, 108145. https://doi.org/10.1016/j.jdiacomp.2022.108145
3. Czupryniak L., Dicker D., Lehmann R. et al. The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?. Cardiovasc Diabetol 20, 198 (2021). https://doi.org/10.1186/s12933-021-01389-1
4. Giubelan L., Dragonu L., Stoian A.C., Dumitrescu F. O analiză intermediară a formelor medii şi severe de COVID-19 tratate în Clinica de Boli Infecţioase Craiova// Revista Română de Boli Infecţioase - Volumul XXIII, Nr. 4, An 2020, p. 272 - 276. https://doi.org/10.37897/RJID.2020.4.4
5. Guisado-Clavero M., Herrero-Gil A., Prrez-Alvarez M., Castelo-Jurado M., Marinas A.H., Ruiz V.A., Iarrondo I.G., Menendez-Orenga M., Ares-Blanco S. Clinical characteristics of SARS-CoV-2 pneumonia diaghosed in a primarycare practicein Madrid (Spain). BMC Family Practice volume22, Article number: 83(2021). https://doi.org/10.1186/s12875-021-01430-y
6. Iancu M.A., Condur L.M., Eremia I., Ticărău A., Diaconu C.C., Matei D. Management of the patient with persistent symptoms after COVID-19 in primary care//Romanian Journal of Medical Practice - Vol. XVI, No. 1 (75), 2021, p. 42 - 45. https://doi.org/10.37897/RJMP.2021.1.7
7. Protocol clinic Naţional «Infecția cu coronavirus de tip nou COVID-19» editia VII aprobat prin ordinul MS nr.32 din 19.01.2022, p. 101.
8. Roberts J., Pritchard A.L., Treweeke A.T., Rossi A.G., Brace1 N., Cahill P., MacRury S.M., Wei J. and Megson I.L. Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System. 2021 Feb 3;7:629933.
9. Sen S, Chakraborty R, Kalita P, Pathak MP. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence. World J Clin Cases. 2021 Oct 6;9(28):8327-8339. PMID: 34754842; PMCID: PMC8554438. https://doi.org/10.12998/wjcc.v9.i28.8327
10. Vudu S., Cazac N., Munteanu D., Vudu L. Impactul COVID-19 la pacienţii cu diabet zaharat şi alte maladii endocrine// Revista de Ştiinţe ale Sănătăţii din Moldova, 2020 Vol. 24(2), p. 49-59.
11. Wong AW, Shah AS, Johnston JC, Carlsten C, Ryerson CJ. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur Respir J. 2020 Nov 26;56(5):2003276. https://doi.org/10.1183/13993003.03276-2020
12. Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27:89. https://doi.org/10.1016/j.cmi.2020.09.023
13. Андреева А. В., Маркова Т. Н., Анциферов М. Б. Особенности ведения пациентов с сахарным диабетом и COVID-19// Доктор.Ру. 2021; 20(2): 11 - 20. DOI: 10.31550/ 1727 - 2378 - 2021-20-2-11-20
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
